İçeriğe geç
akaturk Akademik ölçüm

Makale detayı · 2005

Embolic Events and Char Formation During Pulmonary Vein Isolation in Patients with Atrial Fibrillation: Impact of Different Anticoagulation Regimens and Importance of Intracardiac Echo Imaging

Journal of Cardiovascular Electrophysiology

YÖKSİS OpenAlex SJR Q1 JCR Q1 Atıf 180 Üst %10 Yüzdelik 98.5% FWCI 9.93
Yıl
2005
ISSN
1045-3873
Tür
article

Veri kaynağı ayrımı

  • YÖKSİS YÖKSİS makale kaydı
  • OpenAlex OpenAlex zenginleştirmesi (özet, atıf, konular)

Özet

İngilizce (OpenAlex)

UNLABELLED: Thromboembolic events are important complications of pulmonary vein isolation (PVI) procedures, occurring in up to 2.8% of patients. In this study, we report the incidence of char formation and embolic events with different anticoagulation protocols prospectively changed to reduce such complication. METHODS: A total of 785 patients (mean age: 54 years, 83.5% male) underwent catheter-based PVI for treatment of drug refractory, symptomatic atrial fibrillation (AF). PVI was performed utilizing different strategies including radiofrequency (RF) using temperature control energy delivery and RF using intracardiac echocardiography (ICE)-guided power titration. Patients were divided based on the anticoagulation protocol into three groups: in group 1 (194 patients), activation coagulation time (ACT) was maintained between 250 and 300 seconds; in group 2 (180 patients), ACT was maintained between 300 and 350 seconds plus the IV infusion of eptifibatide (135 microg/kg bolus + 0.5 microg/kg/min); and in group 3 (411 patients), ACT was maintained between 350 and 400 seconds. RESULTS: Char formation was detected in 69 patients of group 1, 5 of group 2, and 8 of group 3. An embolic event was observed in 7 patients of group 1, 3 of group 2, and 2 of group 3 (P = 0.01; group 1 vs group 3). Higher degree of anticoagulation with heparin was associated with a reduced incidence of embolic events even after removing the patients undergoing ICE-guided ablation (P = 0.04). CONCLUSION: More aggressive anticoagulation with heparin reduced periprocedural embolic events. The use of platelet inhibition does not have incremental beneficial effect. None of the anticoagulation protocol abolished char formation.

Konular

  • Atrial Fibrillation Management and Outcomes
  • Venous Thromboembolism Diagnosis and Management
  • Central Venous Catheters and Hemodialysis

Birincil konu Atrial Fibrillation Management and Outcomes

Yazarlar

  1. OUSSAMA M. WAZNI
  2. ANTONIO ROSSILLO
  3. NASSIR F. MARROUCHE
  4. EDUARDO B. SAAD
  5. DAVID O. MARTIN
  6. MANDEEP BHARGAVA
  7. DIANNA BASH
  8. SALWA BEHEIRY
  9. MARK WEXMAN
  10. DOMENICO POTENZA
  11. ENNIO PISANO
  12. RAFFAELE FANELLI
  13. ALDO BONSO
  14. SAKIS THEMISTOCLAKIS
  15. HÜSNİYE DEMET ERCİYEŞ DEMİROĞLU BİLİM ÜNİVERSİTESİ
  16. WALID I. SALIBA
  17. ROBERT A. SCHWEIKERT
  18. JOHANNES BRACHMANN
  19. ANTONIO RAVIELE
  20. ANDREA NATALE